McCarthyPLDolanTF. The serious implications of high fever in infants during their first three months. Clin Pediatr (Phila)1976; 15: 794–6.
2.
HammondJEToselandPA. Placental transfer of chlorpromazine. Arch Dis Child1970; 45: 139–40.
3.
AydFJJr. Children born of mothers treated with chlorpromazine during pregnancy. Clin Med1964; 71: 1758–63.
4.
SobelDE. Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine. Arch Gen Psychiatry1960; 2: 606–11.
5.
Rumeau-RouquetteCGoujardJHuelG. Possible teratogenic effect of phenothiazines in human beings. Teratology1976; 15: 57–64.
6.
HillRMDesmondMMKayJL. Extrapyramidal dysfunction in an infant of a schizophrenic mother. J Pediatr1966; 69: 589–95.
7.
O'ConnorMJohnsonGHJamesDI. Intrauterine effect of phenothiazines. Med J Aust1981; 1: 416–7.
8.
BaldessariniRJ. Drugs and the treatment of psychiatric disorders. In: GilmanAGRallTWNiesASTaylorP, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 383–435.
9.
GardosGColeJOTarsyD. Withdrawal syndromes associated with antipsychotic drugs. Am J Psychiatry1978; 135: 1321–4.
10.
Committee on Drugs.Neonatal drug withdrawal. Pediatrics1983; 72: 895–902.
11.
FaltermanCGRichardsonA. Small left colon syndrome associated with maternal ingestion of psychotropic drugs. J Pediatr1980; 97: 308–10.
12.
KahnAHasaertsDBlumD. Phenothiazine-induced sleep apnea in normal infants. Pediatrics1985; 75: 844–7.
13.
SandykR. Phenothiazine-induced sleep apnea and the opioid system. Pediatrics1986; 77: 261–2.
14.
RewerskjWJGumulkaW. Influence of psychotropic drugs on hypothalamic mechanism of thermoregulation. In: the pharmacology of thermoregulation. Basel: Karger, 1973: 437–46.
15.
CourvoisierSJFournelRDucrotRKolsykyMKoetschetP. Propriétés pharmacodynamiques du chlorhydrate de chloro-3-(dimethyl-amino-3′-propyl)-10-phenothiazine (4.560 R.P.). Arch Int Pharmacodyn Ther1953; 92: 305–61.
16.
GreenblatDJGreenblatRogers G. Chlorpromazine and hyperpyrexia. Clin Pediatr (Phila)1973; 12: 504–5.
